郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data.

期刊：Journal of pharmacokinetics and pharmacodynamics发表年份：2009作者：Agnès Poirier; Anne-Christine Cascais; Christoph Funk; Thierry Lavé
阅读更多 →

药效评价JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2009作者：Ellen E Codd; John R Carson; Raymond W Colburn; Dennis J Stone; Christopher R Van Besien; Sui-Po Zhang; Paul R Wade; Elizabeth L Gallantine; Theo F Meert; Lory Molino; Shirley Pullan; Christine M Razler; Scott L Dax; Christopher M Flores
阅读更多 →

药效评价Biochemical and behavioural characterization of EMPA, a novel high-affinity, selective antagonist for the OX(2) receptor.

期刊：British journal of pharmacology发表年份：2009作者：P Malherbe; E Borroni; L Gobbi; H Knust; M Nettekoven; E Pinard; O Roche; M Rogers-Evans; J G Wettstein; J-L Moreau
阅读更多 →

药效评价Cabergoline: Pharmacology, ocular hypotensive studies in multiple species, and aqueous humor dynamic modulation in the Cynomolgus monkey eyes.

期刊：Experimental eye research发表年份：2009作者：Najam A Sharif; Marsha A McLaughlin; Curtis R Kelly; Parvaneh Katoli; Colene Drace; Shahid Husain; Craig Crosson; Carol Toris; Gui-Lin Zhan; Carl Camras
阅读更多 →